Epidemic disease and the state: Is there a tradeoff between public health and liberty?

This paper examines the political economy of epidemic disease. First, it outlines the incentive and information problems facing policymakers in responding to a new epidemic. Second, it considers the existence of a tradeoff between public health and freedom. Informed by a survey of the history of pub...

Descripción completa

Detalles Bibliográficos
Autor principal: Koyama, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8627289/
https://www.ncbi.nlm.nih.gov/pubmed/34866691
http://dx.doi.org/10.1007/s11127-021-00944-4
_version_ 1784606822846431232
author Koyama, Mark
author_facet Koyama, Mark
author_sort Koyama, Mark
collection PubMed
description This paper examines the political economy of epidemic disease. First, it outlines the incentive and information problems facing policymakers in responding to a new epidemic. Second, it considers the existence of a tradeoff between public health and freedom. Informed by a survey of the history of public health and an analysis of the response to Covid-19, it presents evidence that such a tradeoff can obtain in the short run but that, in the long run, the negative relationship is reversed and the trade-off disappears.
format Online
Article
Text
id pubmed-8627289
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-86272892021-11-29 Epidemic disease and the state: Is there a tradeoff between public health and liberty? Koyama, Mark Public Choice Article This paper examines the political economy of epidemic disease. First, it outlines the incentive and information problems facing policymakers in responding to a new epidemic. Second, it considers the existence of a tradeoff between public health and freedom. Informed by a survey of the history of public health and an analysis of the response to Covid-19, it presents evidence that such a tradeoff can obtain in the short run but that, in the long run, the negative relationship is reversed and the trade-off disappears. Springer US 2021-11-27 2023 /pmc/articles/PMC8627289/ /pubmed/34866691 http://dx.doi.org/10.1007/s11127-021-00944-4 Text en © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Koyama, Mark
Epidemic disease and the state: Is there a tradeoff between public health and liberty?
title Epidemic disease and the state: Is there a tradeoff between public health and liberty?
title_full Epidemic disease and the state: Is there a tradeoff between public health and liberty?
title_fullStr Epidemic disease and the state: Is there a tradeoff between public health and liberty?
title_full_unstemmed Epidemic disease and the state: Is there a tradeoff between public health and liberty?
title_short Epidemic disease and the state: Is there a tradeoff between public health and liberty?
title_sort epidemic disease and the state: is there a tradeoff between public health and liberty?
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8627289/
https://www.ncbi.nlm.nih.gov/pubmed/34866691
http://dx.doi.org/10.1007/s11127-021-00944-4
work_keys_str_mv AT koyamamark epidemicdiseaseandthestateisthereatradeoffbetweenpublichealthandliberty

Ejemplares similares